Tuberculosis

Short Regimen Noninferior for Rifampin-Resistant Tuberculosis

A short regimen for rifapin-resistant tuberculosis was noninferior to 20-month regimen.

Diagnosing Chronic Pulmonary Aspergillosis in Treated Pulmonary TB

By

Sweta Gupta Editor

Chronic pulmonary aspergillosis complicates treated pulmonary tuberculosis frequently.

Effect of Vitamin D Supplementation on Sputum Culture Conversion in Tuberculosis

By

Pulmonology Advisor Contributing Writer

In a subgroup of patients with multidrug-resistant tuberculosis, vitamin D supplementation accelerated sputum culture conversion.

Delamanid Does Not Reduce Time to Sputum Conversion in Multidrug Resistant TB

By

Brandon May

Delamanid was safe and tolerable during a 6-month treatment period in patients with multidrug-resistant tuberculosis.

No Cases of Latent Tuberculosis Reactivation After Hematopoietic Cell Transplantation

By

Sonali Gattani

Risk for developing active tuberculosis has not been previously assessed in patients undergoing hematopoietic cell transplantation.

Multidrug-Resistant TB Outcomes With Pyrazinamide Susceptibility Testing

Introducing pyrazinamide molecular susceptibility testing in the treatment of multidrug-resistant tuberculosis improved outcomes without the use of new drugs and shortened the World Health Organization 20+ month regimen to 12 months.

Experimental TB Vaccine Is in Phase 1 Human Trial

By

Natasha Dyal

A freeze-dried, temperature-stable, experimental tuberculosis vaccine candidate has entered a phase 1 human clinical trial.

New Tuberculosis Vaccine Raises Hope for TB Prevention

By

Tom Greenhalgh

A new vaccine candidate may stave off active TB in M tuberculosis-infected adults.